Additive Interaction Between Onabotulinumtoxin-A and Erenumab in Patients With Refractory Migraine

In the last decade, notable progresses have been observed in chronic migraine preventive treatments. According to the European Headache Federation and national provisions, onabotulinumtoxin-A (BTX-A) and monoclonal antibodies acting on the pathway of calcitonin gene–related peptide (CGRP-mAbs) shoul...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestro, Marcello, Tessitore, Alessandro, Scotto di Clemente, Fabrizio, Battista, Giorgia, Tedeschi, Gioacchino, Russo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060469/
https://www.ncbi.nlm.nih.gov/pubmed/33897608
http://dx.doi.org/10.3389/fneur.2021.656294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060469/
https://www.ncbi.nlm.nih.gov/pubmed/33897608
http://dx.doi.org/10.3389/fneur.2021.656294

Ejemplares similares